-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Co-Diagnostics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q3 2024.
- Co-Diagnostics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $561K, a 33.3% decline year-over-year.
- Co-Diagnostics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $2.61M, a 44.2% decline year-over-year.
- Co-Diagnostics, Inc. annual Nonoperating Income (Expense) for 2023 was $4.6M, a 43.5% decline from 2022.
- Co-Diagnostics, Inc. annual Nonoperating Income (Expense) for 2022 was $8.13M.
- Co-Diagnostics, Inc. annual Nonoperating Income (Expense) for 2021 was -$429K, a 149% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)